glp-1 therapies success rate GLP‑1 Therapy Improves Atrial Fibrillation Outcomes After Catheter Ablation, Miller School Study Finds GLP-1 RAs gain popularity as

While retatrutide mainly works by making us eat less, it also increases how much energy we use, which is also important

Greater Weight Loss Clinical Trial Data: In the Phase 2 TRIUMPH-1 study , retatrutide achieved unprecedented levels of weight loss : Up to 24.2% average total body weight loss at 48 weeks Over 26% weight loss at the highest dose (12 mg weekly) In comparison: Tirzepatides weight loss peaked at about 22.5% in SURMOUNT-1 at 72 weeks This suggests faster, more significant fat loss in less time with retatrutide

Unlike injectables like semaglutide or tirzepatide, oral drugs such as Orforglipron offer convenient, daily dosing options

GLP-1 Receptor Agonists: A New Treatment in Parkinsons Disease

This lipid shell protects the glutathione as it travels through the stomach